Juergen Wichmann

770 total citations
12 papers, 572 citations indexed

About

Juergen Wichmann is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Juergen Wichmann has authored 12 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Juergen Wichmann's work include Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (7 papers) and Pain Mechanisms and Treatments (4 papers). Juergen Wichmann is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (7 papers) and Pain Mechanisms and Treatments (4 papers). Juergen Wichmann collaborates with scholars based in Switzerland, United States and Italy. Juergen Wichmann's co-authors include François Jenck, Geo Adam, Jean‐Luc Moreau, Andrea M. Cesura, S. Roever, Frank M. Dautzenberg, Kenneth Lundström, James R. Martin, Sabine Kolczewski and Gavin J. Kilpatrick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Juergen Wichmann

11 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juergen Wichmann Switzerland 10 514 434 199 57 45 12 572
Jeanette Georgieva Sweden 10 480 0.9× 352 0.8× 132 0.7× 49 0.9× 44 1.0× 25 584
Paul Marquez United States 13 317 0.6× 220 0.5× 143 0.7× 39 0.7× 36 0.8× 17 397
S. Roever Switzerland 4 275 0.5× 239 0.6× 81 0.4× 47 0.8× 31 0.7× 6 324
Beverley Nicol United Kingdom 7 363 0.7× 261 0.6× 143 0.7× 12 0.2× 54 1.2× 11 416
Sally E. Hays United States 13 467 0.9× 343 0.8× 70 0.4× 43 0.8× 69 1.5× 17 624
N M Appel United States 10 401 0.8× 226 0.5× 63 0.3× 42 0.7× 14 0.3× 12 533
J. Wichmann Switzerland 9 337 0.7× 271 0.6× 68 0.3× 19 0.3× 21 0.5× 9 363
A.J. Prange United States 11 502 1.0× 355 0.8× 90 0.5× 111 1.9× 68 1.5× 15 704
Pernilla Fagergren Sweden 8 252 0.5× 184 0.4× 113 0.6× 39 0.7× 11 0.2× 9 433
Smriti Iyengar United States 9 294 0.6× 226 0.5× 72 0.4× 80 1.4× 21 0.5× 9 420

Countries citing papers authored by Juergen Wichmann

Since Specialization
Citations

This map shows the geographic impact of Juergen Wichmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Wichmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Wichmann more than expected).

Fields of papers citing papers by Juergen Wichmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Wichmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Wichmann. The network helps show where Juergen Wichmann may publish in the future.

Co-authorship network of co-authors of Juergen Wichmann

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Wichmann. A scholar is included among the top collaborators of Juergen Wichmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Wichmann. Juergen Wichmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Samuels, Benjamin A., Michael Saxe, Juergen Wichmann, et al.. (2024). Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged Male Mice. SHILAP Revista de lepidopterología. 5(2). 100419–100419.
2.
Célanire, Sylvain, Iyassu K. Sebhat, Juergen Wichmann, et al.. (2014). Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present). Expert Opinion on Therapeutic Patents. 25(1). 69–90. 26 indexed citations
3.
Goeldner, Celia, Theresa M. Ballard, Frédéric Knoflach, et al.. (2012). Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target. Neuropharmacology. 64. 337–346. 75 indexed citations
4.
Reiss, David J., et al.. (2007). Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: Comparison to morphine. European Journal of Pharmacology. 579(1-3). 141–148. 47 indexed citations
5.
Chiou, Lih‐Chu, et al.. (2004). Ro 64-6198 [(1 S,3 aS)-8-(2,3,3 a,4,5,6-Hexahydro-1 H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] Acts Differently from Nociceptin/Orphanin FQ in Rat Periaqueductal Gray Slices. Journal of Pharmacology and Experimental Therapeutics. 311(2). 645–651. 27 indexed citations
6.
Kotlińska, Jolanta H., et al.. (2003). Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence. Neuroreport. 14(4). 601–604. 23 indexed citations
7.
Pen, Gwenaëlle Le, Juergen Wichmann, Jean‐Luc Moreau, & François Jenck. (2002). The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats. Neuroreport. 13(4). 451–454. 29 indexed citations
8.
Ciccocioppo, Roberto, et al.. (2002). Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology. 161(2). 113–119. 63 indexed citations
9.
Rizzi, Daniela, Raffaella Bigoni, Anna Rizzi, et al.. (2001). Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(5). 551–555. 37 indexed citations
10.
11.
Roever, S., Geo Adam, Andrea M. Cesura, et al.. (2000). ChemInform Abstract: High‐Affinity, Nonpeptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor.. ChemInform. 31(28). 9 indexed citations
12.
Jenck, François, Juergen Wichmann, Frank M. Dautzenberg, et al.. (2000). A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat. Proceedings of the National Academy of Sciences. 97(9). 4938–4943. 235 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeanette Georgieva Breakdown of academic impact, for papers by Paul Marquez Breakdown of academic impact, for papers by S. Roever Breakdown of academic impact, for papers by Beverley Nicol Breakdown of academic impact, for papers by Sally E. Hays Breakdown of academic impact, for papers by N M Appel Breakdown of academic impact, for papers by J. Wichmann Breakdown of academic impact, for papers by A.J. Prange Breakdown of academic impact, for papers by Pernilla Fagergren Breakdown of academic impact, for papers by Smriti Iyengar
Rankless by CCL
2026